Volume 27, Number 5—May 2021
Clinical Laboratory Perspective on Streptococcus halichoeri, an Unusual Nonhemolytic, Lancefield Group B Streptococcus Causing Human Infections
|Isolate||Hemolysis||Catalase-SBA||Catalase-MHA||PYR||Esculin||Bile-esculin||Hippurate||Lancefield B antigen|
|076||Negative||Weak positive||Negative||Positive||Positive||Positive||Negative||Weak positive|
*MHA, Mueller-Hinton agar; PYR, pyrrolidonyl arylamidase; SBA, sheep blood agar. †Isolate from patient described in case 1. ‡Isolate from patient described in case 2.
1These authors contributed equally to this article.
Page created: March 15, 2021
Page updated: April 20, 2021
Page reviewed: April 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.